Screening of Cancer Through Novel Female Specific Biomarkers
Status unconfirmed
Conditions studied: Cancer
In brief
Can reliable biomarkers be identified for detection of cancer at early stages using menstrual blood (MB)? Preliminary mass spectrometry (MS) results suggest that MB provides biomarkers for identification of disease such as cancers.
Key facts
- Study ID
- NCT03951428
- Run by
- LifeStory Health Inc.
- People needed
- 60
- Starts
- 2019-05-15
- Expected to finish
- 2019-12-31
- Last updated by the study team
- 2019-05-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- are 18 years or older
- are either healthy or have a recent diagnosis of breast, endometrial or lung cancer and have not yet begun treatment (your doctor will provide the stage of cancer at time of enrollment)
- are willing and able to comply with the study requirements
- have a negative pregnancy test prior to enrolling in this study
- Have provided all current medication usage and accurately reported disease history (both current and past) and completed the health profile provided at time of enrollment
- currently menstruating
You may not qualify if…
- have a generalized infection (bacterial, viral or fungal), or obvious localized infections in the vaginal area
- have any active sexually transmitted diseases•if you become pregnant while on the study, you must withdraw from the study.
- have received an investigational drug within four weeks prior to the study or who plan to use other investigational drugs duringthis study.
- have severe medical condition(s) that in the view of the investigator prohibits participation in the study.
Where it is running
- Vasicek Cancer Treatment Center — Temple, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.